Stocks

Biogen: What’s the Story behind Old Buddy Rocking the Neighborhood?

 Stocks

Beyond new surge of meme stocks, one of the most widely discussed news of the past week came in the form of approval for Biogen’s (BIIB) Alzheimer's drug Aduhelm. The approval polarized both the scientific and stock trading community. The stock, which on the day of the approval at one point peaked at about 64% gain, ended the week up about 40%.

June 14, 2021

views 2285

Popular posts

Stocks

Alibaba’s Earnings vs. China’s Regulatory Actions: Waiting for Stock Reentry Signals

August 4, 2021

views 2736
Commodities

Gold and Precious Metals: Landscape is Changing Outside our Windows

May 24, 2021

views 2723
Cryptocurrencies

Ethereum “London” Change of Protocol: Big Deal or Much Ado About Nothing?

August 6, 2021

views 2631
Cryptocurrencies

Why Robinhood IPO is Highly Contingent on Crypto Market Performance

July 2, 2021

views 2538
Stocks

Microchip Shortage Saga is Nowhere Near the End

June 1, 2021

views 2457
show more

Tech summary box

top crypto

© 2024 DR Techinnovate

Client Agreement AML Policy Refund and Withdrawal policy Privacy Policy

Trading financial instruments involves substantial risk and is not suitable for all investors. The information herein is not a recommendation to trade nor investment research or an offer to buy or sell any instrument. It does not take into account your particular investment objectives, financial situation or needs and does not create a binding obligation on any of the DR Techinnovate Company to enter into any transaction with you. You are advised to perform an independent investigation of any transaction to determine whether any transaction is suitable for you.